←Back to list

Aidoc

Developer of a decision support software designed to empower physicians to improve patient outcomes.
Developer of a decision support software designed to empower physicians to improve patient outcomes.
Decision/Risk Analysis 📍 New York, NY Founded 2016
Current Valuation
$1.8B
as of 2025-Q3
UNICORN

QL Price

$3.3B
+87% vs last round
QuantLogix's current estimate for Aidoc, published 2026-09-27 — above the last disclosed round of $1.8B (2025-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round $1.8B 2025-Q3 weight 0.5
Secondary market print $4.6B 2026-06-27 weight 0.58
How this price has held up
No round has priced for Aidoc since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Aidoc →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Aidoc, 2026-09-27 (353635ced84ed73e). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Aidoc going public?
No. Aidoc is private and has not filed to go public. There is no S-1 on file.
What is Aidoc's valuation in 2026?
Aidoc is valued at $1.8B as of 2025-Q3, set by its Later Stage VC ($150M, Jul 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Aidoc filed an S-1?
No public S-1 is on file for Aidoc.
How much has Aidoc raised?
Aidoc has raised $434.26M in total, most recently a Later Stage VC of $150M in Jul 2025.
Is Aidoc publicly traded — can you buy Aidoc stock?
No. Aidoc is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Aidoc on its Pre-IPO Access Desk.
How to actually get exposure to Aidoc →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
2016
HQ
New York, NY
Employees
488
Total Raised
$434.26M
Last Round
Later Stage VC — $150M (Jul 2025)
IPO Status
private

Fundraising Status

Later Stage VC · $150M · 1y 2mo ago
privateTotal raised $434.26M

Secondary Market

Implied price / share
$27.59
Last round price / share
$10.53
vs last round
+162.0%
Open interest
3
Last round price vs secondary price
Last round vs current secondary price per share$10.53Last round$27.59Current
Secondary price return by period
Secondary market period returns3-month-0.8%6-month-4.2%1-year+765%All-time+688%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Later Stage VC$150MJul 2025—$1.8B

Vertical Intelligence — AI / ML

No verified Hugging Face organization found for Aidoc — no attributable open-model footprint. Closed-weights labs are common; this is a distribution signal, not a capability judgment.
Checked huggingface.co as of 2026-09-27. Re-checked weekly.

Talent Signal

Hiring trend
▼ Hiring downtrend
-14% vs 2026-08
Open roles
51
via careers page
Product-build share
61%
engineering, research, product, design
Trajectory
tightening
product-led hiring — 61% of open roles build product; the rest are go-to-market and G&A.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by month59Aug '2651Sep '26
Open roles by function
Open roles by functionEngineering21Sales & GTM6Ops & People5Finance & Strategy4Clinical & Science4Security4Legal & Policy4Data & ML2Marketing1
■ product-building   ■ go-to-market / G&A
Clinical Studies & SummariesSenior Data Engineer \\ \\ Tel Aviv-Yafo, Tel Aviv District, IsraelBackend Tech Lead\\ \\ Tel Aviv-Yafo, Tel Aviv District, IsraelCore Backend Engineer\\ \\ Tel Aviv-Yafo, Tel Aviv District, IsraelPrincipal Software Engineer\\ \\ Tel Aviv-Yafo, Tel Aviv District, IsraelSenior DevOps Engineer \\ \\ Tel Aviv-Yafo, Tel Aviv District, Israel
Counted from Aidoc's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareMachine LearningArtificial IntelligenceMedical Device
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q3. Refreshed quarterly.